Get an alert when BELL,SONS & CO.(DRUGGISTS)LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

£8.2M

+15.1% highest in 3 filed years

Net assets

£32M

+3.1% highest in 3 filed years

Employees

202

+5.8% vs 2025

Profit before tax

£2.7M

-56.7% lowest in 3 filed years

Accounts

3-year trend · Δ = latest vs prior filed period · latest reflected 2026-03-31

Metric Trend 2024-03-312025-03-312026-03-31 Δ vs prior
Turnover £53,652,924£51,868,281£47,508,891 -8.4%
Operating profit £7,582,273£6,151,982£2,666,728 -56.7%
Profit before tax £7,588,182£6,151,982£2,666,728 -56.7%
Net profit £5,510,660£4,781,448£1,966,392 -58.9%
Cash £7,083,255£7,148,176£8,230,494 +15.1%
Total assets less current liabilities £26,508,814£31,209,563£32,159,550 +3%
Net assets £25,982,340£30,763,788£31,730,180 +3.1%
Equity £25,982,340£30,763,788£31,730,180 +3.1%
Average employees 204191202 +5.8%
Wages £5,995,803£5,630,110£5,161,702 -8.3%
Directors' remuneration £279,367£448,847£107,002 -76.2%

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show . About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-03-312025-03-312026-03-31
Operating margin 14.1%11.9%5.6%
Net margin 10.3%9.2%4.1%
Return on capital employed 28.6%19.7%8.3%
Current ratio 3.27x3.76x5.93x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Auditor
PBG Associates Limited
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“Based on the Company's financial performance, cash flow forecasts, and continued demand for its pharmaceutical products in both UK and international markets, the Directors consider it appropriate to adopt the going concern basis of accounting.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

8 active · 20 resigned

Name Role Appointed Born Nationality
CHISNALL, Daniel Secretary 2025-06-25
CHISNALL, Daniel Director 2026-04-01 May 1996 British
KONASAGAR JAYANNA, Sathish Kumar Director 2016-10-08 Apr 1973 British
MOHANTY, Abhinna Sundar Director 2025-06-25 Oct 1953 Indian
MURPHY, Kevin Roy Director 2026-05-28 Mar 1972 British
SALDANHA, Mark Bosco Director 2008-01-18 Aug 1972 Indian
SALDANHA, Sandra Director 2017-03-31 Dec 1971 Indian
SHARMA, Jitendra Mahavirprasad Director 2017-03-31 Jun 1969 Indian
Show 20 resigned officers
Name Role Appointed Resigned
BARLOW, David Secretary 2008-03-28 2016-05-31
JACKS, Gillian Secretary 2016-06-01 2025-06-26
KANANI, Hitesh Secretary 2008-01-18 2008-03-28
MOSELEY, John Edward Secretary 2008-01-18
BARLOW, David Director 2009-07-12 2016-05-31
BUDDHARAJU, Seetharama Raju Director 2020-05-12 2025-06-25
COX, Francis Joseph Anthony Director 2008-01-18
GULLIVER, Brian Thomas Director 2012-03-19 2016-10-07
HALE, Graham Director 2008-01-18
HALE, Philip Director 1996-06-01 2008-01-18
HALE, Vera Margaret Director 2008-01-18
HUNTER, Colin Director 2019-05-17 2024-05-10
JACKS, Gillian Director 2016-06-01 2017-03-31
LUNT, Brian Edward Director 2008-07-01
MOLYNEUX, John Stephen Director 2024-05-09 2026-03-31
MOSELEY, John Edward Director 2008-01-18
ROBERTS, Karl, Dr Director 2010-07-19 2012-03-19
SHEPHERD, Linda Director 2008-01-18
WELLS, Kenneth Edward Director 2008-07-01 2009-07-12
WILLIAMS, Russell David Director 2017-03-31 2019-03-27

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Marksans Holdings Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Active

Filing timeline

Last 20 of 169 total filings

Date Type Category Description
2026-06-04 AA accounts Accounts with accounts type full
2026-05-28 AP01 officers Appoint person director company with name date PDF
2026-04-15 AP01 officers Appoint person director company with name date PDF
2026-04-01 TM01 officers Termination director company with name termination date PDF
2025-10-22 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-07-03 TM01 officers Termination director company with name termination date PDF
2025-07-03 AP01 officers Appoint person director company with name date PDF
2025-07-03 AP03 officers Appoint person secretary company with name date PDF
2025-07-01 TM02 officers Termination secretary company with name termination date PDF
2025-05-30 AA accounts Accounts with accounts type full
2024-10-14 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-09-04 AA accounts Accounts with accounts type full
2024-05-13 TM01 officers Termination director company with name termination date PDF
2024-05-13 AP01 officers Appoint person director company with name date PDF
2023-11-06 MR04 mortgage Mortgage satisfy charge full PDF
2023-11-06 MR04 mortgage Mortgage satisfy charge full PDF
2023-10-19 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-07-14 AA accounts Accounts with accounts type full
2022-10-17 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-06-09 AA accounts Accounts with accounts type full

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
9

last 12 months

Capital events
0

last 24 months

Officers appointed
2

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page